Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Osmol initiates IND-enabling studies of OSM-0205 for prevention of CIPN

May 17, 2021

FDA approves Zynrelef for postsurgical analgesia

May 14, 2021

Protein kinase analysis identifies potential therapeutic targets for Friedreich's ataxia

May 14, 2021

Merck & Co. divulges new LRRK2 inhibitors

May 14, 2021

Sumitomo Dainippon Pharma to study DSP-0038 in phase I for Alzheimer's disease psychosis

May 14, 2021

Engineering blood cells can treat brain diseases

May 13, 2021

Clene Nanomedicine presents preliminary phase II data for CNM-Au8 in ALS

May 13, 2021

Ono Pharmaceutical, Vanderbilt University present KCNT1/KCNK2 blockers

May 13, 2021

Minerva reports phase III OLE data on roluperidone for negative symptoms of schizophrenia

May 12, 2021

Alairion presents histamine H1 receptor inverse agonists and 5-HT2A receptor antagonists

May 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...